Septerna SEPN
NASDAQ SEPN
$39.13 -0.61 (-1.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Septerna (SEPN) Receivables (2023 - 2026)

Updated

Septerna (SEPN) reported Receivables of $12.16 million for Q2 2026, compared with $151,000 a year earlier and up 12.2% from the prior quarter.

Analysis

Septerna (SEPN) Receivables (2023 - 2026) Analysis & Trends

At the end of FY2025, Septerna posted Receivables of $10.36 million.

  • By year, Receivables came in at $345,000 in FY2024 (-98.5%) and $22.63 million in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly Receivables since Q4 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $10.84 million (Q1 2026), $10.36 million (Q4 2025) and $9.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Septerna 1.81 Bn 1.81 Bn - 12.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.16 Mn
Mar 31, 2026 10.84 Mn
Dec 31, 2025 10.36 Mn
Sep 30, 2025 9.80 Mn
Jun 30, 2025 151,000.00
Mar 31, 2025 250,000.00
Dec 31, 2024 345,000.00
Sep 30, 2024 210,000.00
Dec 31, 2023 22.63 Mn
API Access

Septerna Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=SEPN&period=max&api_key=YOUR_API_KEY